Stockreport

Newly Published Data Continue to Support Long-Term Efficacy of TEPEZZA® (teprotumumab-trbw) for Thyroid Eye Disease (TED)

Horizon Therapeutics Public Limited Company - Ordinary Shares  (HZNP) 
Last horizon therapeutics public limited company - ordinary shares earnings: 2/26 07:00 am Check Earnings Report
PDF -- Comprehensive OPTIC-X trial results published in Ophthalmology, including new long-term follow-up data -- DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq [Read more]